Steve Miller is COO at CATALYST PHARMACEUTICALS, INC. (CPRX). They have made 12 open-market trades across 1 company since 2012, most recently 2025-12-29.
CIK 0001402535
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $253K since 2012, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CPRX | 1,093,803 | $34.4M |
Shares reported on the most recent Form 4, priced at the 2025-12-30 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CPRX | SELL | 2025-08-26 | 2025-08-28 | $20.28 | $2.3M | -3.4% | -4.4% | +14.6% |
| CPRX | SELL | 2024-12-10 | 2024-12-11 | $21.93 | $1.1M | -1.2% | +0.3% | -4.1% |
| CPRX | SELL | 2024-08-20 | 2024-08-22 | $20.33 | $4.1M | -4.0% | -1.2% | +2.0% |
| CPRX | SELL | 2023-12-05 | 2023-12-07 | $14.24 | $570K | +3.8% | +6.5% | +11.8% |
| CPRX | SELL | 2022-11-21 | 2022-11-23 | $15.69 | $1.6M | -2.8% | +12.3% | -9.9% |
| CPRX | SELL | 2022-09-13 | 2022-09-15 | $16.94 | $2.4M | -5.1% | -0.2% | +35.4% |
| CPRX | SELL | 2022-08-18 | 2022-08-19 | $13.51 | $2.5M | -2.9% | -7.0% | +9.7% |
| CPRX | SELL | 2021-08-25 | 2021-08-26 | $5.56 | $890K | -6.1% | -3.7% | +36.9% |
| CPRX | SELL | 2021-08-13 | 2021-08-17 | $6.09 | $499K | -4.2% | -13.0% | +27.8% |
| CPRX | BUY | 2016-01-11 | 2016-01-12 | $1.80 | $14K | +6.7% | -11.3% | -41.0% |
| CPRX | BUY | 2014-06-04 | 2014-06-04 | $2.17 | $217K | -17.6% | -4.9% | -4.9% |
| CPRX | BUY | 2012-07-03 | 2012-07-05 | $0.55 | $22K | -17.6% | -4.9% | -4.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.